Latest News

Date Title Topic
14 Nov 2017 Abiraterone in castrate-sensitive prostate cancer Genitourinary cancers
14 Nov 2017 Generic Fulvestrant Receives a Positive Opinion from the EMA CHMP Breast cancer - Anticancer agents & Biologic therapy
13 Nov 2017 EMA Recommends Approval of Biosimilar Bevacizumab Anticancer agents & Biologic therapy
13 Nov 2017 ESMO Press Release: ESMO Precision Medicine Glossary Published Today
10 Nov 2017 FDA Approves Brentuximab Vedotin for the Treatment of Adult Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma or CD30-Expressing Mycosis Fungoides Haematologic malignancies - Anticancer agents & Biologic therapy
eUpdate – Treatment Algorithms
09 Nov 2017 Assessment, Grading and Management of Acute Toxicities From CAR-T-Cell Therapy Palliative and supportive care - Cancer Immunology and Immunotherapy
08 Nov 2017 FDA Approves Alectinib for ALK Positive Metastatic NSCLC Lung and other thoracic tumours - Personalised medicine - Anticancer agents & Biologic therapy
06 Nov 2017 ESMO Media Alert: ESMO Asia 2017 Congress
06 Nov 2017 Distinct Cancer Profiles Described Among Young Adults Aged 20 to 39 Years Epidemiology/Etiology/Cancer Prevention
03 Nov 2017 FDA Grants Accelerated Approval to Acalabrutinib for Mantle Cell Lymphoma Haematologic malignancies - Anticancer agents & Biologic therapy
02 Nov 2017 ESMO Media Alert: Cancer Research to be Presented at ESMO Asia Congress in Singapore
02 Nov 2017 Predictive Model May Determine Risk of Subsequent CNS Tumour in Survivors of Childhood Cancer Central nervous system malignancies - Translational research - Cancer in Special Situations
02 Nov 2017 Patient Guide in NSCLC Now Available in Italian